Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.2851
H.R.2851: To prohibit application of a payment limit to a drug or biological under part B of the Medicare Program based on a less costly alternative for courses of treatment begun before the change in payment.
About This Bill
- This bill was introduced in the 105th Congress
- This bill is primarily about congress
- Introduced Nov. 6, 1997
- Latest Major Action Nov. 14, 1997
Bill Sponsor
Bill Summary
Provides that, if the Secretary of Health and Human Services or a carrier reduces a recognized rate for a drug or biological under part B (Supplementary Medical Insurance) of title XVIII (Medicare) of the Social Security Act based solely on the identification of an alternative drug or biological that is less costly for treatment of the same condition, the Secretary shall provide that such reduction shall not apply during a course of treatment...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
|
Referred to House Commerce
|
|
Referred to House Ways and Means
|
|
Referred to the Subcommittee on Health.
|
|
Referred to the Subcommittee on Health and Environment.
|
|
Nov. 6, 1997 |
Introduced in the House by Barbara B. Kennelly (D-Conn.) |